Histopathological correlations of islet amyloidosis with apolipoprotein e polymorphisms in type 2 diabetic chinese patients

Pancreas

Volumn 42, Issue 7, 2013, Pages 1129-1137

  Guan, Jing ^a   Zhao, Hai Lu ^a   Sui, Yi ^a   He, Lan ^a   Lee, Heung Man ^a   Lai, Fernand M M ^a   Tong, Peter C Y ^a,b   Chan, Juliana C N ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

amylin; amyloidosis; apolipoprotein E; arteriosclerosis; type 2 diabetes mellitus

Indexed keywords

AMYLIN; AMYLOID P COMPONENT; APOLIPOPROTEIN E; GENOMIC DNA; THIOFLAVINE;

AGED; AMYLOIDOSIS; ARTERIOSCLEROSIS; ARTICLE; AUTOPSY; CHINESE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HYALINE DEGENERATION; IMMUNOREACTIVITY; LIGASE DETECTION REACTION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTION ANALYSIS;

AGED; AGED, 80 AND OVER; AMYLOIDOSIS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PANCREATIC DISEASES; POLYMORPHISM, GENETIC; SERUM AMYLOID P-COMPONENT;

EID: 84885174282     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182965e6e     Document Type: Article

References (35)

1. Cooper GJ, Day AJ, Willis AC, et al. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim Biophys Acta. 1989;1014:247-258. (Pubitemid 20009797)
2. Howard CF Jr. Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia. 1986;29:301-306. (Pubitemid 16080927)
3. Guardado-Mendoza R, Davalli AM, Chavez AO, et al. Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci U S A. 2009;106:13992-13997.
4. Maloy AL, Longnecker DS, Greenberg ER. The relation of islet amyloid to the clinical type of diabetes. Hum Pathol. 1981;12:917-922. (Pubitemid 12227621)
5. Sakagashira S, Sanke T, Hanabusa T, et al. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes. 1996;45:1279-1281. (Pubitemid 26296332)
6. Poa NR, Cooper GJ, Edgar PF. Amylin gene promoter mutations predispose to type 2 diabetes in New Zealand Maori. Diabetologia. 2003;46:574-578. (Pubitemid 36577803)
7. Sakagashira S, Hiddinga HJ, Tateishi K, et al. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am J Pathol. 2000;157:2101-2109.
8. Powell DS, Maksoud H, Charge SB, et al. Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes. Diabetes Res Clin Pract. 2003;60:105-110. (Pubitemid 36434261)
9. Chen L, Baum L, Ng HK, et al. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset. Hum Pathol. 1999;30:1172-1177. (Pubitemid 29480885)
10. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes. 2002;51:1256-1262. (Pubitemid 34438377)
11. Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507-537.
12. Yip AG, McKee AC, Green RC, et al. APOE, vascular pathology, and the AD brain. Neurology. 2005;65:259-265. (Pubitemid 41022371)
13. Zhao HL, Tong PC, Lai FM, et al. Association of glomerulopathy with the 5¶-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients. Diabetes. 2004;53:2984-2991. (Pubitemid 39425925)
14. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004 Jan; 27 Suppl 1:S5-S10.
15. Potter KJ, Abedini A, Marek P, et al. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A. 2010;107:4305-4310.
16. Khanna M, Park P, Zirvi M, et al. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Oncogene. 1999;18:27-38. (Pubitemid 29060576)
17. Cooper GJ. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev. 1994;15:163-201. (Pubitemid 24129182)
18. Cui D, Hoshii Y, Takahashi M, et al. An immunohistochemical study of amyloid P component, apolipoprotein E and ubiquitin in human and murine amyloidoses. Pathol Int. 1998;48:362-367. (Pubitemid 28355160)
19. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology. 1999;53:1308-1311. (Pubitemid 29480092)
20. Charge SB, Esiri MM, Bethune CA, et al. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease. J Pathol. 1996;179:443-447. (Pubitemid 26276117)
21. Lei P, Wu WH, Li RW, et al. Prevention and promotion effects of apolipoprotein E4 on amylin aggregation. Biochem Biophys Res Commun. 2008;368:414-418.
22. Castillo MJ, Scheen AJ, Lefebvre PJ. Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. Diabete Metab. 1995;21:3-25.
23. Tan KC, Shiu SW, Wong Y, et al. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus. Diabetes Metab Res Rev. 2006;22:307-312. (Pubitemid 44070507)
24. Nickenig G, Sachinidis A, Michaelsen F, et al. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation. 1997;95:473-478. (Pubitemid 27056216)
25. ZelenyM, Swertfeger DK,Weisgraber KH, et al. Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation. Biochemistry. 2002;41:11820-11823.
26. Altenburg M, Johnson L, Wilder J, et al. Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner. J Biol Chem. 2007;282:7817-7824. (Pubitemid 47093587)
27. Westermark GT, Westermark P, Berne C, et al. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med. 2008;359:977-979.
28. Tennent GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A. 1995;92:4299-4303.
29. Zhao HL, Lai FM, Tong PC, et al. Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes. 2003;52:2759-2766. (Pubitemid 37339705)
30. Westermark P, Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand A. 1973;81:291-300.
31. Clark A, Saad MF, Nezzer T, et al. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia. 1990;33:285-289. (Pubitemid 20161883)
32. Bell ET. Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol. 1959;35:801-805.
33. Saito K, Yaginuma N, Takahashi T. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med. 1979;129:273-283. (Pubitemid 10136627)
34. Ohsawa H, Kanatsuka A, Mizuno Y, et al. Islet amyloid polypeptide-derived amyloid deposition increases along with the duration of type 2 diabetes mellitus. Diabetes Res Clin Pract. 1992;15:17-21.
35. Clark A, Cooper GJ, Lewis CE, et al. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet. 1987;2:231-234. (Pubitemid 17101086)